Litigation Details for Gilead Sciences, Inc. v. Lupin Limited (D. Del. 2021)
✉ Email this page to a colleague
Gilead Sciences, Inc. v. Lupin Limited (D. Del. 2021)
| Docket | ⤷ Sign Up | Date Filed | 2021-11-16 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:1 Patent Infringement | Assigned To | Maryellen Noreika |
| Jury Demand | None | Referred To | |
| Parties | GILEAD SCIENCES, INC. | ||
| Patents | 10,039,718 | ||
| Attorneys | Irena Royzman | ||
| Firms | Phillips, Goldman, McLaughlin & Hall, P.A. | ||
| Link to Docket | External link to docket | ||
Details for Gilead Sciences, Inc. v. Lupin Limited (D. Del. 2021)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2021-11-16 | 1 | Complaint | U.S. Patent No. 10,039,718 (the “’718 patent”) and U.S. Patent No. 10,786,518 (the “’518 patent”) (together…Orange Book Patents- In-Suit”), and U.S. Patent No. 8,497,396 (the “’396 patent”) and U.S. Patent No. 9,428,473…“’473 patent”) (together, the “Process Patents-In-Suit”) (all patents collectively, the “Patents-In- …the expiration of the ’718 patent, ’518 patent, ’396 patent and ’473 patent (including such actions by… infringement of the ’718 patent, ’518 patent, ’396 patent and ’473 patent under 35 U.S.C. §§ 271 (a) | External link to document |
| 2023-07-07 | 141 | Notice of Service | Invalidity Contentions Regarding U.S. Patent No. 10,039,718 (the 718 Patent) filed by Lupin Limited, Lupin Pharmaceuticals…16 November 2021 1:21-cv-01621 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
